This is consistent with our recent observation in a population wide prospective study in NSW, where the likelihood of PSA testing increased with increased frequency of GP visits, and also for those with at least one non-prostate related medical condition (Nair-Shalliker et al. under review). Here, KLK3 is linked to prostatitis.